CymitQuimica logo

CAS 952652-79-8

:

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 8 productos.
  • Valsartan Related Compound B (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine)

    CAS:
    Aromatic or modified aromatic drugs with nitrogen heter
    Fórmula:C23H27N5O3
    Forma y color:White Powder
    Peso molecular:421.21139
  • Valsartan n-Propyl

    CAS:
    Fórmula:C23H27N5O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:421.4922

    Ref: IN-DA00IIWL

    10mg
    157,00€
    25mg
    221,00€
    50mg
    331,00€
    100mg
    658,00€
  • Valsartan EP Impurity C (Valsartan USP Related Compound B)

    CAS:
    Fórmula:C23H27N5O3
    Forma y color:Off-White Solid
    Peso molecular:421.50

    Ref: 4Z-V-026

    5mg
    A consultar
    10mg
    508,00€
    25mg
    825,00€
    50mg
    1.153,00€
    100mg
    A consultar
  • Valsartan Impurity 46

    CAS:
    Fórmula:C25H31N5O3
    Forma y color:Off-White Solid
    Peso molecular:449.56

    Ref: 4Z-V-0268

    5mg
    A consultar
    10mg
    A consultar
    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • Valsartan n-Propyl Impurity

    Producto controlado
    CAS:
    <p>Impurity Valsartan Related Compound B<br>Applications Valsartan n-Propyl is an impurity in the synthesis of Valsartan (V095750). Valsartan USP Related Compound B.<br>References Hillaert, S., et al.: J. Pharm. Biomed. Anal., 31, 329 (2003), Carlucci, G., et al.: Anal. Lett., 33, 2491 (2000), Cagigal, E., et al.: Talanta, 54, 1121 (2001),<br></p>
    Fórmula:C23H27N5O3
    Forma y color:White
    Peso molecular:421.49

    Ref: TR-V095770

    10mg
    363,00€
    25mg
    899,00€
    100mg
    2.480,00€
  • Valsartan EP Impurity C

    CAS:
    Fórmula:C23H27N5O3
    Peso molecular:421.49

    Ref: ST-EA-CP-V3003

    10mg
    A consultar
    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

    CAS:
    <p>N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine (GW1929) is a potent vasodilator that is used for the treatment of hypertension. It is synthesized by condensation of sodium hydroxide with 2-(4′-chlorophenyl)piperazine followed by methyl esterification and chloride acylation. The synthesis of GW1929 has been accomplished in two steps: carbonate cyclization and valsartan hydrolysis. In the first step, the carboxylic acid group of GW1929 was converted to its corresponding chloride compound which was then reacted with methyl bromide to yield the desired product. The second step involved hydrolysis of GW1929 with potassium carbonate, after which it was oxidized with azide to form an ester. Sodium</p>
    Fórmula:C23H27N5O3
    Pureza:Min. 95%
    Forma y color:White Powder
    Peso molecular:421.49 g/mol

    Ref: 3D-IO28664

    1mg
    233,00€
    2mg
    341,00€
    5mg
    486,00€
    10mg
    748,00€
    25mg
    1.356,00€